| 000 | 01049 a2200277 4500 | ||
|---|---|---|---|
| 005 | 20250518033355.0 | ||
| 264 | 0 | _c20191223 | |
| 008 | 201912s 0 0 eng d | ||
| 022 | _a1873-4286 | ||
| 024 | 7 |
_a10.2174/138161282444190329154841 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aYalçın, A Süha | |
| 245 | 0 | 0 |
_aRedox Regulation and Cancer Therapy. _h[electronic resource] |
| 260 |
_bCurrent pharmaceutical design _c2018 |
||
| 300 |
_a5232-5233 p. _bdigital |
||
| 500 | _aPublication Type: Editorial; Introductory Journal Article | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
| 650 | 0 | 4 |
_aAntioxidants _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aOxidation-Reduction _xdrug effects |
| 650 | 0 | 4 |
_aReactive Oxygen Species _xantagonists & inhibitors |
| 700 | 1 | _aKarademir, Betül | |
| 773 | 0 |
_tCurrent pharmaceutical design _gvol. 24 _gno. 44 _gp. 5232-5233 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2174/138161282444190329154841 _zAvailable from publisher's website |
| 999 |
_c29576953 _d29576953 |
||